X4 Pharmaceuticals (XFOR) Financial Statements
Price: $0.1908
Market Cap: $33.13M
Avg Volume: 3.32M
Market Cap: $33.13M
Avg Volume: 3.32M
Country: US
Industry: Biotechnology
Sector: Healthcare
Industry: Biotechnology
Sector: Healthcare
Overview of Financial Statements
Financial statements are records that provide an overview of a company's financial performance and position. There are three main types of financial statements:
- Income Statement: Shows the company's revenue, expenses, and profit over a specific period.
- Balance Sheet: Provides a snapshot of the company's assets, liabilities, and equity at a specific point in time.
- Cash Flow Statement: Details the cash inflows and outflows from operating, investing, and financing activities over a period.
This page presents both annual and quarterly data for these financial statements. The charts below provide a visual representation of the key metrics from each statement, helping you to quickly understand the financial health of X4 Pharmaceuticals.
Income Statement
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 | December 31, 2019 | December 31, 2018 | December 31, 2017 | December 31, 2016 | December 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.56M | $- | $- | $- | $3.00M | $- | $3.50M | $- | $- | $- |
| Cost of Revenue | $797.00K | $2.00M | $1.99M | $1.89M | $- | $672.00K | $103.00K | $195.00K | $300.00K | $400.00K |
| Gross Profit | $1.76M | $-2.00M | $-1.99M | $-1.89M | $3.00M | $-672.00K | $3.40M | $-195.00K | $-300.00K | $-400.00K |
| Gross Profit Ratio | 68.83% | - | - | - | 100.00% | - | 97.06% | - | - | - |
| Research and Development Expenses | $81.64M | $70.02M | $61.06M | $50.65M | $41.93M | $30.16M | $30.98M | $28.13M | $17.83M | $12.71M |
| General and Administrative Expenses | $- | $- | $- | $24.70M | $20.94M | $17.64M | $18.41M | $8.01M | $6.51M | $2.12M |
| Selling and Marketing Expenses | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Selling General and Administrative Expenses | $61.52M | $35.51M | $27.02M | $24.70M | $20.94M | $17.64M | $18.41M | $8.01M | $6.51M | $2.12M |
| Other Expenses | $-105.00M | $- | $-6.27M | $-3.57M | $-2.11M | $-1.10M | $-85.00K | $-16.00K | $104.00K | $-77.00K |
| Operating Expenses | $38.16M | $107.52M | $88.08M | $75.35M | $62.87M | $47.80M | $46.21M | $32.27M | $21.96M | $12.67M |
| Cost and Expenses | $38.96M | $107.52M | $88.08M | $75.35M | $62.87M | $47.80M | $46.21M | $32.27M | $21.96M | $12.67M |
| Interest Income | $5.77M | $4.58M | $219.00K | $10.00K | $273.00K | $1.20M | $809.00K | $214.00K | $- | $- |
| Interest Expense | $8.77M | $5.78M | $3.99M | $3.64M | $2.69M | $2.15M | $1.04M | $2.08M | $2.52M | $472.00K |
| Depreciation and Amortization | $796.00K | $419.00K | $1.99M | $1.89M | $1.23M | $672.00K | $103.00K | $195.00K | $300.00K | $389.00K |
| EBITDA | $-27.58M | $-107.10M | $-87.57M | $-85.11M | $-58.06M | $-51.70M | $-45.88M | $-31.60M | $-20.16M | $-12.35M |
| EBITDA Ratio | -1078.45% | - | - | - | -1935.50% | - | -1311.00% | - | - | - |
| Operating Income | $-36.40M | $-107.52M | $-87.57M | $-85.11M | $-59.87M | $-51.70M | $-45.88M | $-36.13M | $-24.35M | $-14.82M |
| Operating Income Ratio | -1423.58% | - | - | - | -1995.80% | - | -1311.00% | - | - | - |
| Total Other Income Expenses Net | $-739.00K | $6.43M | $-6.27M | $-3.57M | $-2.11M | $-1.10M | $2.86M | $2.26M | $6.48M | $1.61M |
| Income Before Tax | $-37.14M | $-101.09M | $-93.84M | $-88.68M | $-61.98M | $-52.81M | $-43.02M | $-33.88M | $-22.98M | $-13.22M |
| Income Before Tax Ratio | -1452.48% | - | - | - | -2066.10% | - | -1229.17% | - | - | - |
| Income Tax Expense | $310.00K | $78.00K | $28.00K | $17.00K | $148.00K | $3.80M | $3.90M | $1.87M | $2.62M | $395.00K |
| Net Income | $-37.45M | $-101.17M | $-93.87M | $-88.70M | $-62.13M | $-56.60M | $-43.02M | $-33.88M | $-22.98M | $-13.22M |
| Net Income Ratio | -1464.61% | - | - | - | -2071.03% | - | -1229.17% | - | - | - |
| EPS | $-0.19 | $-0.57 | $-1.48 | $-3.44 | $-3.09 | $-4.91 | $-93.73 | $-98.58 | $-24.76 | $-14.24 |
| EPS Diluted | $-0.19 | $-0.57 | $-1.48 | $-3.44 | $-3.09 | $-4.91 | $-93.73 | $-98.58 | $-24.76 | $-14.24 |
| Weighted Average Shares Outstanding | 201.06M | 177.81M | 63.53M | 25.75M | 20.08M | 11.53M | 459.00K | 343.64K | 928.01K | 928.01K |
| Weighted Average Shares Outstanding Diluted | 201.06M | 177.81M | 63.53M | 25.75M | 20.08M | 11.53M | 459.00K | 343.64K | 928.01K | 928.01K |
| SEC Filing | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source |
Balance Sheet
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 | December 31, 2019 | December 31, 2018 | December 31, 2017 | December 31, 2016 | December 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and Cash Equivalents | $55.70M | $99.22M | $121.72M | $81.79M | $78.71M | $126.18M | $30.75M | $76.79M | $3.04M | $6.76M |
| Short Term Investments | $46.36M | $15.00M | $- | $- | $- | $- | $- | $- | $- | $- |
| Cash and Short Term Investments | $102.06M | $114.22M | $121.72M | $81.79M | $78.71M | $126.18M | $30.75M | $76.79M | $3.04M | $6.76M |
| Net Receivables | $1.71M | $562.00K | $1.15M | $747.00K | $917.00K | $2.00M | $2.86M | $1.61M | $1.34M | $1.54M |
| Inventory | $2.82M | $- | $- | $- | $- | $- | $- | $355.00K | $1.25M | $- |
| Other Current Assets | $5.59M | $7.30M | $5.81M | $5.34M | $3.68M | $1.10M | $1.47M | $1.13M | $1.34M | $87.00K |
| Total Current Assets | $112.17M | $122.08M | $128.68M | $87.88M | $83.31M | $129.28M | $35.08M | $80.83M | $5.72M | $8.39M |
| Property Plant Equipment Net | $4.84M | $6.39M | $8.33M | $10.22M | $9.20M | $2.36M | $285.00K | $421.00K | $519.00K | $760.00K |
| Goodwill | $17.35M | $17.35M | $17.35M | $17.35M | $27.11M | $27.11M | $- | $- | $- | $- |
| Intangible Assets | $10.00M | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Goodwill and Intangible Assets | $27.35M | $17.35M | $17.35M | $17.35M | $27.11M | $27.11M | $- | $- | $- | $- |
| Long Term Investments | $- | $- | $1.02M | $1.32M | $1.73M | $1.90M | $364.00K | $355.00K | $394.00K | $338.00K |
| Tax Assets | $- | $- | $-1.02M | $-1.32M | $-1.73M | $-1.90M | $- | $- | $- | $- |
| Other Non-Current Assets | $2.08M | $1.44M | $1.23M | $1.72M | $3.26M | $1.95M | $275.00K | $-355.00K | $975.00K | $25.00K |
| Total Non-Current Assets | $34.27M | $25.18M | $26.91M | $29.30M | $39.56M | $31.42M | $924.00K | $421.00K | $1.89M | $1.12M |
| Other Assets | $- | $- | $- | $- | $- | $- | $- | $-0 | $- | $- |
| Total Assets | $146.45M | $147.26M | $155.59M | $117.18M | $122.87M | $160.70M | $36.00M | $81.25M | $7.60M | $9.51M |
| Account Payables | $8.62M | $8.95M | $7.78M | $4.28M | $3.14M | $2.09M | $545.00K | $1.89M | $1.65M | $423.00K |
| Short Term Debt | $1.25M | $1.10M | $3.71M | $2.94M | $1.57M | $1.80M | $1.69M | $2.31M | $3.49M | $2.07M |
| Tax Payables | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Deferred Revenue | $- | $- | $- | $- | $- | $- | $737.00K | $2.63M | $504.00K | $430.00K |
| Other Current Liabilities | $23.00M | $12.82M | $10.84M | $6.79M | $7.23M | $5.56M | $2.43M | $5.78M | $4.78M | $3.33M |
| Total Current Liabilities | $32.88M | $22.86M | $22.32M | $14.02M | $11.95M | $9.45M | $5.40M | $7.68M | $12.06M | $6.68M |
| Long Term Debt | $2.82M | $57.18M | $35.91M | $37.91M | $37.66M | $22.02M | $7.89M | $9.92M | $-29.71M | $-25.24M |
| Deferred Revenue Non-Current | $- | $- | $- | $- | $- | $- | $1.11M | $2.63M | $2.05M | $2.43M |
| Deferred Tax Liabilities Non-Current | $- | $- | $- | $- | $- | $- | $- | $-9.00K | $39.84M | $29.95M |
| Other Non-Current Liabilities | $88.60M | $16.11M | $23.30M | $826.00K | $462.00K | $16.00K | $5.00K | $9.00K | $-39.75M | $-29.88M |
| Total Non-Current Liabilities | $91.42M | $73.30M | $59.21M | $38.74M | $38.12M | $22.03M | $9.01M | $14.87M | $52.11M | $37.16M |
| Other Liabilities | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Liabilities | $124.30M | $96.16M | $81.53M | $52.76M | $50.07M | $31.48M | $14.40M | $22.55M | $64.17M | $43.83M |
| Preferred Stock | $- | $- | $- | $- | $- | $160.70M | $65.41M | $81.25M | $39.84M | $29.95M |
| Common Stock | $171.00K | $167.00K | $122.00K | $28.00K | $16.00K | $16.00K | $15.00K | $15.00K | $1.00K | $1.00K |
| Retained Earnings | $-515.36M | $-477.90M | $-376.74M | $-282.87M | $-194.18M | $-132.04M | $-135.29M | $-92.27M | $-58.39M | $-35.41M |
| Accumulated Other Comprehensive Income Loss | $-122.00K | $-119.00K | $-119.00K | $-119.00K | $-119.00K | $-119.00K | $241.00K | $127.00K | $834.00K | $718.00K |
| Other Total Stockholders Equity | $537.46M | $528.96M | $450.79M | $347.37M | $267.08M | $261.37M | $156.63M | $150.83M | $40.83M | $-29.95M |
| Total Stockholders Equity | $22.15M | $51.10M | $74.05M | $64.41M | $72.80M | $129.22M | $21.60M | $58.71M | $-56.56M | $-34.32M |
| Total Equity | $22.15M | $51.10M | $74.05M | $64.41M | $72.80M | $129.22M | $21.60M | $58.71M | $-56.56M | $-34.32M |
| Total Liabilities and Stockholders Equity | $146.45M | $147.26M | $155.59M | $117.18M | $122.87M | $160.70M | $36.00M | $81.25M | $7.60M | $9.51M |
| Minority Interest | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Liabilities and Total Equity | $146.45M | $147.26M | $155.59M | $117.18M | $122.87M | $160.70M | $36.00M | $81.25M | $7.60M | $9.51M |
| Total Investments | $46.36M | $15.00M | $1.02M | $1.32M | $1.73M | $1.90M | $364.00K | $355.00K | $394.00K | $338.00K |
| Total Debt | $2.66M | $58.28M | $38.42M | $39.78M | $38.45M | $22.91M | $7.89M | $12.24M | $15.29M | $7.19M |
| Net Debt | $-53.04M | $-40.94M | $-83.30M | $-42.00M | $-40.26M | $-103.27M | $-22.86M | $-64.56M | $12.25M | $435.00K |
Cash Flow Statement
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 | December 31, 2019 | December 31, 2018 | December 31, 2017 | December 31, 2016 | December 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | $-37.45M | $-101.17M | $-93.87M | $-88.70M | $-62.13M | $-52.81M | $-43.02M | $-33.88M | $-22.98M | $-13.22M |
| Depreciation and Amortization | $796.00K | $419.00K | $513.00K | $499.00K | $351.00K | $103.00K | $155.00K | $195.00K | $285.00K | $389.00K |
| Deferred Income Tax | $- | $- | $- | $-6.68M | $-5.78M | $-2.15M | $- | $-269.00K | $-1.39M | $-1.00K |
| Stock Based Compensation | $8.20M | $8.69M | $5.20M | $6.18M | $5.43M | $2.05M | $5.62M | $906.00K | $644.00K | $126.00K |
| Change in Working Capital | $- | $344.00K | $5.74M | $-1.50M | $-4.06M | $-3.24M | $-4.46M | $3.42M | $-517.00K | $1.45M |
| Accounts Receivables | $-1.07M | $- | $-610.00K | $- | $- | $- | $-1.37M | $-64.00K | $152.00K | $-56.00K |
| Inventory | $-2.82M | $- | $610.00K | $- | $- | $- | $- | $- | $- | $- |
| Accounts Payables | $-286.00K | $1.23M | $3.42M | $1.17M | $1.03M | $-2.75M | $-1.34M | $182.00K | $1.26M | $77.00K |
| Other Working Capital | $- | $-890.00K | $2.31M | $-2.66M | $-5.09M | $-484.00K | $-3.12M | $3.24M | $-1.78M | $1.37M |
| Other Non Cash Items | $-102.45M | $-4.79M | $5.32M | $19.29M | $7.38M | $7.99M | $804.00K | $1.75M | $2.32M | $441.00K |
| Net Cash Provided by Operating Activities | $-130.90M | $-96.51M | $-77.10M | $-70.91M | $-58.82M | $-48.05M | $-40.90M | $-27.87M | $-21.64M | $-10.82M |
| Investments in Property Plant and Equipment | $-326.00K | $-60.00K | $-103.00K | $-615.00K | $-1.36M | $-174.00K | $-34.00K | $-42.00K | $-73.00K | $-170.00K |
| Acquisitions Net | $- | $- | $- | $- | $- | $26.41M | $- | $- | $- | $- |
| Purchases of Investments | $-57.13M | $-16.82M | $-4.80M | $- | $- | $- | $- | $- | $-65.00K | $-77.00K |
| Sales Maturities of Investments | $26.45M | $2.00M | $- | $- | $- | $- | $- | $- | $- | $- |
| Other Investing Activities | $98.00M | $- | $4.80M | $- | $- | $1.00M | $- | $76.00K | $-65.00K | $-77.00K |
| Net Cash Used for Investing Activities | $66.99M | $-14.88M | $-103.00K | $-615.00K | $-1.36M | $27.23M | $-34.00K | $34.00K | $-138.00K | $-247.00K |
| Debt Repayment | $20.00M | $20.44M | $-795.00K | $- | $12.39M | $481.00K | $2.40M | $3.28M | $12.76M | $4.50M |
| Common Stock Issued | $- | $60.00M | $122.63M | $75.98M | $-277.00K | $139.39M | $4.47M | $66.00M | $5.50M | $7.02M |
| Common Stock Repurchased | $- | $- | $- | $-2.00M | $- | $- | $-1.13M | $-197.00K | $-87.00K | $-12.00K |
| Dividends Paid | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Other Financing Activities | $294.00K | $8.08M | $-4.61M | $260.00K | $283.00K | $792.00K | $4.47M | $31.98M | $5.38M | $7.00M |
| Net Cash Used Provided by Financing Activities | $20.29M | $88.52M | $117.23M | $74.25M | $12.39M | $140.66M | $-4.53M | $101.26M | $18.15M | $11.51M |
| Effect of Forex Changes on Cash | $-156.00K | $99.00K | $-105.00K | $-319.00K | $402.00K | $-250.00K | $-286.00K | $333.00K | $-94.00K | $-122.00K |
| Net Change in Cash | $-43.77M | $-22.78M | $39.92M | $2.41M | $-47.38M | $119.59M | $-45.75M | $73.76M | $-3.72M | $320.00K |
| Cash at End of Period | $56.48M | $100.25M | $123.03M | $83.11M | $80.70M | $128.09M | $31.39M | $76.79M | $3.04M | $6.76M |
| Cash at Beginning of Period | $100.25M | $123.03M | $83.11M | $80.70M | $128.09M | $8.50M | $77.15M | $3.04M | $6.76M | $6.44M |
| Operating Cash Flow | $-130.90M | $-96.51M | $-77.10M | $-70.91M | $-58.82M | $-48.05M | $-40.90M | $-27.87M | $-21.64M | $-10.82M |
| Capital Expenditure | $-326.00K | $-60.00K | $-103.00K | $-615.00K | $-1.36M | $-174.00K | $-34.00K | $-42.00K | $-73.00K | $-170.00K |
| Free Cash Flow | $-131.23M | $-96.57M | $-77.20M | $-71.52M | $-60.18M | $-48.23M | $-40.94M | $-27.91M | $-21.71M | $-10.99M |